返回
Identifying problems and solutions in scientific text
DOI:10.1007/s11192-018-2718-6.png)
摘要
En 中文
Research is often described as a problem-solving activity, and as a result, descriptions of problems and solutions are an essential part of the scientific discourse used to describe research activity. We present an automatic classifier that, given a phrase that may or may not be a description of a scientific problem or a solution, makes a binary decision about problemhood and solutionhood of that phrase. We recast the problem as a supervised machine learning problem, define a set of 15 features correlated with the target categories and use several machine learning algorithms on this task. We also create our own corpus of 2000 positive and negative examples of problems and solutions. We find that we can distinguish problems from non-problems with an accuracy of 82.3%, and solutions from non-solutions with an accuracy of 79.7%. Our three most helpful features for the task are syntactic information (POS tags), document and word embeddings.
Keyword:
Problem-solving patterns
Machine learning
Discourse
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.5
论文数:
8.1K
被引数:
2.2W
机构
引用论文
Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible脆性X综合征小鼠模型的感知学习受损是由小白蛋白神经元功能障碍介导的,并且是可逆的
Efficient organic DSSC sensitizers bearing an electron-deficient pyrimidine as an effective π-spacer
Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?促肾上腺皮质激素释放因子的生理和行为反应: CRF是焦虑或应激反应的中介物吗?
Effect of Subcutaneous and Intraperitoneal Administration of Recombinant Human Erythropoietin on Blood Pressure and Vasoactive Hormones in Patients on Continuous Ambulatory Peritoneal Dialysis
Nephron
IF0
A phase III, randomized, open-label, multicenter, global study of first-line durvalumab plus standard of care (SoC) chemotherapy and durvalumab plus tremelimumab, and SoC chemotherapy versus SoC chemotherapy alone in unresectable locally advanced or metastatic urothelial cancer (NILE).一线durvalumab加护理标准 (SoC) 化疗和durvalumab加tremelimumab,以及SoC化疗与单独SoC化疗治疗不可切除的局部晚期或转移性尿路上皮癌 (NILE) 的III期,随机,开放标签,多中心,全球研究。

